(Q38396256)

English

A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospective randomized study

scientific article published on 03 February 2016

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospective randomized study (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

Dominick Angiolillo

14

object named as

Dominick J Angiolillo

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

author name string

Fabiana Rollini

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Francesco Franchi

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Jung Rae Cho

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Christopher DeGroat

4

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Mona Bhatti

5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Ana Muniz-Lozano

6

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Kamaldeep Singh

7

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Elisabetta Ferrante

8

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Ryan E Wilson

9

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Elizabeth C Dunn

10

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Martin M Zenni

11

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Luis A Guzman

12

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Theodore A Bass

13

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

publication date

3 February 2016

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

European Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

2722-2730

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Novel antiplatelet agents in acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV744

21 January 2018

Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV744

21 January 2018

Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV744

21 January 2018

Prasugrel versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV744

21 January 2018

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV744

21 January 2018

Meta-analysis of direct and indirect comparison of ticagrelor and prasugrel effects on platelet reactivity

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV744

21 January 2018

High on-treatment platelet reactivity with ticagrelor versus prasugrel: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV744

21 January 2018

Design and analysis of pilot studies: recommendations for good practice.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV744

21 January 2018

Switching P2Y12-receptor inhibitors in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV744

21 January 2018

Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (SWitching Anti Platelet) study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV744

21 January 2018

Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV744

21 January 2018

Effect on platelet reactivity from a prasugrel loading dose after a clopidogrel loading dose compared with a prasugrel loading dose alone: Transferring From Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients (TRIP

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV744

21 January 2018

Relationship between degree of P2Y12 receptor blockade and inhibition of P2Y12-mediated platelet function

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV744

21 January 2018

Pharmacodynamic evaluation of switching from ticagrelor to prasugrel in patients with stable coronary artery disease: Results of the SWAP-2 Study (Switching Anti Platelet-2).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV744

21 January 2018

Impact of prasugrel reload dosing regimens on high on-treatment platelet reactivity rates in patients on maintenance prasugrel therapy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV744

21 January 2018

Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thro

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV744

21 January 2018

Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV744

21 January 2018

Adenosine-mediated effects of ticagrelor: evidence and potential clinical relevance

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV744

21 January 2018

Randomized comparison of ticagrelor versus prasugrel in patients with acute coronary syndrome and planned invasive strategy--design and rationale of the iNtracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (IS

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV744

21 January 2018

Long-term use of ticagrelor in patients with prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV744

21 January 2018

Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel, or placebo in the ONSET/OFFSET study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV744

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHV744

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38396256&oldid=2224720778"